China Regenerative Medicine International Dirección
Dirección controles de criterios 3/4
El CEO de China Regenerative Medicine International es Chuang Wang , nombrado en Jul 2020, tiene una permanencia de 4.33 años. compensación anual total es HK$1.46M, compuesta por 85.3% salario y 14.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 24.28% de las acciones de la empresa, por valor de HK$31.77M. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 3.9 años, respectivamente.
Información clave
Chuang Wang
Chief Executive Officer (CEO)
HK$1.5m
Compensación total
| Porcentaje del salario del CEO | 85.3% |
| Permanencia del CEO | 4.3yrs |
| Participación del CEO | 24.3% |
| Permanencia media de la dirección | 4.3yrs |
| Promedio de permanencia en la Junta Directiva | 3.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding
Mar 05
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%
Jan 04These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively
Sep 21China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet
Jun 11Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
May 22Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
Apr 13Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Sep 22Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year
Mar 16What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?
Feb 08Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares
Dec 15
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)
Nov 25Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Nov 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -HK$104m |
| Mar 31 2024 | n/a | n/a | -HK$101m |
| Dec 31 2023 | HK$1m | HK$1m | -HK$108m |
| Sep 30 2023 | n/a | n/a | HK$677k |
| Jun 30 2023 | n/a | n/a | HK$15m |
| Mar 31 2023 | n/a | n/a | HK$5m |
| Dec 31 2022 | HK$1m | n/a | HK$5m |
| Sep 30 2022 | n/a | n/a | HK$31m |
| Jun 30 2022 | n/a | n/a | HK$26m |
| Mar 31 2022 | n/a | n/a | HK$49m |
| Dec 31 2021 | HK$1m | n/a | HK$52m |
| Sep 30 2021 | n/a | n/a | -HK$95m |
| Jun 30 2021 | n/a | n/a | -HK$82m |
| Mar 31 2021 | n/a | n/a | -HK$105m |
| Dec 31 2020 | HK$1m | n/a | -HK$120m |
| Sep 30 2020 | n/a | n/a | -HK$201m |
| Jun 30 2020 | n/a | n/a | -HK$237m |
| Mar 31 2020 | n/a | n/a | -HK$239m |
| Dec 31 2019 | HK$245k | HK$245k | -HK$264m |
Compensación vs. Mercado: La compensación total ($USD188.03K) de Chuang está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD233.89K).
Compensación vs. Ingresos: La compensación de Chuang ha aumentado mientras la empresa no es rentable.
CEO
Chuang Wang (45 yo)
4.3yrs
Permanencia
HK$1,461,000
Compensación
Mr. Chuang Wang has been Executive Chairman at China Regenerative Medicine International Limited since October 18, 2019 and serves as its Chief Executive Officer since July 9, 2020 and also serves as its C...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, Executive Chairman & Compliance Officer | 4.3yrs | HK$1.46m | 24.28% HK$ 31.8m | |
| CFO & Company Secretary | 2.2yrs | sin datos | sin datos | |
| Chief Technology Officer | 6.2yrs | sin datos | sin datos |
4.3yrs
Permanencia media
45yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 8158 se considera experimentado (4.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, Executive Chairman & Compliance Officer | 5.1yrs | HK$1.46m | 24.28% HK$ 31.8m | |
| Independent Non-Executive Director | 2.9yrs | HK$120.00k | sin datos | |
| Independent Non-Executive Director | 4.8yrs | HK$120.00k | sin datos | |
| Independent Non-Executive Director | 2.9yrs | HK$120.00k | sin datos |
3.9yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de 8158 se considera experimentada (3.9 años de antigüedad promedio).